Gene · 84649
Papers1,612
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,612
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Aryl hydrocarbon receptor-dependent lipid droplet accumulation supports redox homeostasis in hypoxia-induced PCa cells. | Am J Cancer Res | 2026 | 42724686 | PubTator, text mining | PubMed |
| Di(2-ethylhexyl) phthalate and mono(2-ethylhexyl) phthalate upregulate PPARG and induce metabolic reprogramming in hepatocellular carcinoma cells: a pan-cancer and metabolomics study. | Food Chem Toxicol | 2026 | 42674152 | PubTator, text mining | PubMed |
| Lipid droplet dynamics control type I interferon responses and viperin expression to suppress viral replication. | Vet Microbiol | 2026 | 42623889 | PubTator, text mining | PubMed |
| Deletion of Pleiotrophin protects against high-fat diet-induced liver metabolic disease, independently of the sexual dimorphism in dietary response. | Mol Biomed | 2026 | 42622926 | PubTator, text mining | PubMed |
| CEBPB as a candidate mediator of DEGDB-induced tumor-associated phenotypes in colorectal cancer cells. | Ecotoxicol Environ Saf | 2026 | 42617514 | PubTator, text mining | PubMed |
| A pan-genome perspective uncovers the core genetic basis and evolutionary adaptation of lipid synthesis and vesicular transport in Nannochloropsis. | J Phycol | 2026 | 42615245 | PubTator, text mining | PubMed |
| Pharmacologic management of metabolic and alcohol-associated liver disease. | Metab Target Organ Damage | 2026 | 42577825 | PubTator, text mining | PubMed |
| DGAT2 inhibition in MASH: histologic promise and lipid paradox. | Hepatobiliary Surg Nutr | 2026 | 42569416 | PubTator, text mining | PubMed |
| Microglial checkpoint collapse in Alzheimer's disease: a tri-axial framework for biomarker-informed neuroimmune therapy. | J Neuroinflammation | 2026 | 42393750 | PubTator, text mining | PubMed |
| Dual IRE1 targets: Determinants of the cell fate? | FEBS J | 2026 | 42298872 | PubTator, text mining | PubMed |
| The immunometabolic mechanisms and therapeutic targets of metabolic dysfunction-associated steatohepatitis. | Front Med (Lausanne) | 2026 | 42245952 | PubTator, text mining | PubMed |
| Exploring glycerophospholipid metabolism in nasopharyngeal carcinoma: interactions between malignant epithelial cells and CCL11-expressing fibroblasts. | Front Immunol | 2026 | 42245668 | PubTator, text mining | PubMed |
| Diacylglycerol enantiomer selectivity of diacylglycerol acyltransferases highlights metabolic specialization in triacylglycerol synthesis across the tree of life. | Biosci Rep | 2026 | 42240445 | PubTator, text mining | PubMed |
| Extracellular Vesicles in Alzheimer's Disease: Mechanisms, Immunotherapy Links, and Clinical Translation. | Curr Pharm Des | 2026 | 42152645 | PubTator, text mining | PubMed |
| Transcriptomic profiling for identifying differentially expressed genes in aneurysm. | Bioinformation | 2026 | 42145366 | PubTator, text mining | PubMed |
| Human absorption, distribution, metabolism, excretion, and reaction phenotyping of ervogastat (PF-06865571), a diacylglycerol O-acyltransferase 2 inhibitor. | Drug Metab Dispos | 2026 | 42061200 | PubTator, text mining | PubMed |
| Coordination of Lipid Storage and Mobilization Pathways During Osteoblast Maturation in a 3D Human Bone Model. | Int J Mol Sci | 2026 | 41977501 | PubTator, text mining | PubMed |
| Skeletal Muscle and Circulating microRNAs Adaptations to 12-Week HIIT With or Without L-Citrulline in Obese Older Adults. | J Cachexia Sarcopenia Muscle | 2026 | 41933456 | PubTator, text mining | PubMed |
| Regulatory T cells in axial spondyloarthritis. | Commun Biol | 2026 | 41917236 | PubTator, text mining | PubMed |
| The Crimean-Congo haemorrhagic fever virus hijacks the liver lipid metabolic pathway for virion production. | Emerg Microbes Infect | 2026 | 41911362 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/84649/papers